| Symbol |
Name |
|
ACTA1
|
actin, alpha 1, skeletal muscle
|
|
ACTA2
|
actin, alpha 2, smooth muscle, aorta
|
|
ACTB
|
actin, beta
|
|
ACTC1
|
actin, alpha, cardiac muscle 1
|
|
ACTG1
|
actin gamma 1
|
|
ACTG2
|
actin, gamma 2, smooth muscle, enteric
|
|
ADAMTS1
|
ADAM metallopeptidase with thrombospondin type 1 motif, 1
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AJUBA
|
ajuba LIM protein
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT1S1
|
AKT1 substrate 1 (proline-rich)
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
AKT3
|
v-akt murine thymoma viral oncogene homolog 3
|
|
AMOT
|
angiomotin
|
|
ANGPT1
|
angiopoietin 1
|
|
ANGPT2
|
angiopoietin 2
|
|
ANGPT4
|
angiopoietin 4
|
|
APC
|
adenomatous polyposis coli
|
|
AREG
|
amphiregulin
|
|
ASXL1
|
additional sex combs like transcriptional regulator 1
|
|
ATF2
|
activating transcription factor 2
|
|
ATF3
|
activating transcription factor 3
|
|
ATG13
|
autophagy related 13
|
|
ATM
|
ATM serine/threonine kinase
|
|
AXIN1
|
axin 1
|
|
BAG2
|
BCL2-associated athanogene 2
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BAP1
|
BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)
|
|
BARD1
|
BRCA1 associated RING domain 1
|
|
BAX
|
BCL2-associated X protein
|
|
BBC3
|
BCL2 binding component 3
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BECN1
|
beclin 1, autophagy related
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BTC
|
betacellulin
|
|
BTRC
|
beta-transducin repeat containing E3 ubiquitin protein ligase
|
|
BUB1B-PAK6
|
BUB1B-PAK6 readthrough
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL4
|
chemokine (C-C motif) ligand 4
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCN2
|
cellular communication network factor 2
|
|
CCND1
|
cyclin D1
|
|
CCND2
|
cyclin D2
|
|
CCND3
|
cyclin D3
|
|
CCNE1
|
cyclin E1
|
|
CD274
|
CD274 molecule
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD47
|
CD47 molecule
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH10
|
cadherin 10, type 2 (T2-cadherin)
|
|
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast)
|
|
CDH12
|
cadherin 12, type 2 (N-cadherin 2)
|
|
CDH13
|
cadherin 13
|
|
CDH15
|
cadherin 15, type 1, M-cadherin (myotubule)
|
|
CDH16
|
cadherin 16, KSP-cadherin
|
|
CDH17
|
cadherin 17, LI cadherin (liver-intestine)
|
|
CDH18
|
cadherin 18, type 2
|
|
CDH19
|
cadherin 19, type 2
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
|
CDH20
|
cadherin 20, type 2
|
|
CDH22
|
cadherin 22, type 2
|
|
CDH24
|
cadherin 24, type 2
|
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental)
|
|
CDH4
|
cadherin 4, type 1, R-cadherin (retinal)
|
|
CDH5
|
cadherin 5, type 2 (vascular endothelium)
|
|
CDH6
|
cadherin 6, type 2, K-cadherin (fetal kidney)
|
|
CDH7
|
cadherin 7, type 2
|
|
CDH8
|
cadherin 8, type 2
|
|
CDH9
|
cadherin 9, type 2 (T1-cadherin)
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDK7
|
cyclin-dependent kinase 7
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CER1
|
cerberus 1, DAN family BMP antagonist
|
|
CHD8
|
chromodomain helicase DNA binding protein 8
|
|
CIT
|
citron rho-interacting serine/threonine kinase
|
|
COL4A1
|
collagen, type IV, alpha 1
|
|
COL4A2
|
collagen, type IV, alpha 2
|
|
COL4A3
|
collagen, type IV, alpha 3 (Goodpasture antigen)
|
|
COL4A4
|
collagen, type IV, alpha 4
|
|
COL4A5
|
collagen, type IV, alpha 5
|
|
COL4A6
|
collagen, type IV, alpha 6
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CSF1
|
colony stimulating factor 1 (macrophage)
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
|
CSNK1A1
|
casein kinase 1, alpha 1
|
|
CSNK1A1L
|
casein kinase 1, alpha 1-like
|
|
CSNK1E
|
casein kinase 1, epsilon
|
|
CSNK2A1
|
casein kinase 2, alpha 1 polypeptide
|
|
CSNK2A2
|
casein kinase 2, alpha prime polypeptide
|
|
CSNK2A3
|
casein kinase 2, alpha 3 polypeptide
|
|
CSNK2B
|
casein kinase 2, beta polypeptide
|
|
CTBP1
|
C-terminal binding protein 1
|
|
CTBP2
|
C-terminal binding protein 2
|
|
CTHRC1
|
collagen triple helix repeat containing 1
|
|
CTNNA1
|
catenin (cadherin-associated protein), alpha 1, 102kDa
|
|
CTNNA2
|
catenin (cadherin-associated protein), alpha 2
|
|
CTNNA3
|
catenin (cadherin-associated protein), alpha 3
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CUL1
|
cullin 1
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL5
|
chemokine (C-X-C motif) ligand 5
|
|
CXXC4
|
CXXC finger protein 4
|
|
CYCS
|
cytochrome c, somatic
|
|
DDIT3
|
DNA-damage-inducible transcript 3
|
|
DEPTOR
|
DEP domain containing MTOR-interacting protein
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
|
DKK2
|
dickkopf WNT signaling pathway inhibitor 2
|
|
DKK4
|
dickkopf WNT signaling pathway inhibitor 4
|
|
DSC3
|
desmocollin 3
|
|
DVL1
|
dishevelled segment polarity protein 1
|
|
DVL2
|
dishevelled segment polarity protein 2
|
|
DVL3
|
dishevelled segment polarity protein 3
|
|
E2F1
|
E2F transcription factor 1
|
|
EED
|
embryonic ectoderm development
|
|
EFNA1
|
ephrin-A1
|
|
EFNA2
|
ephrin-A2
|
|
EFNA3
|
ephrin-A3
|
|
EFNA4
|
ephrin-A4
|
|
EFNA5
|
ephrin-A5
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF4B
|
eukaryotic translation initiation factor 4B
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
EIF4G1
|
eukaryotic translation initiation factor 4 gamma, 1
|
|
ELK1
|
ELK1, member of ETS oncogene family
|
|
EPHA2
|
EPH receptor A2
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
FABP4
|
fatty acid binding protein 4, adipocyte
|
|
FGF1
|
fibroblast growth factor 1 (acidic)
|
|
FGF10
|
fibroblast growth factor 10
|
|
FGF11
|
fibroblast growth factor 11
|
|
FGF12
|
fibroblast growth factor 12
|
|
FGF13
|
fibroblast growth factor 13
|
|
FGF14
|
fibroblast growth factor 14
|
|
FGF17
|
fibroblast growth factor 17
|
|
FGF18
|
fibroblast growth factor 18
|
|
FGF19
|
fibroblast growth factor 19
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF20
|
fibroblast growth factor 20
|
|
FGF21
|
fibroblast growth factor 21
|
|
FGF22
|
fibroblast growth factor 22
|
|
FGF23
|
fibroblast growth factor 23
|
|
FGF3
|
fibroblast growth factor 3
|
|
FGF4
|
fibroblast growth factor 4
|
|
FGF5
|
fibroblast growth factor 5
|
|
FGF6
|
fibroblast growth factor 6
|
|
FGF7
|
fibroblast growth factor 7
|
|
FGF8
|
fibroblast growth factor 8 (androgen-induced)
|
|
FGF9
|
fibroblast growth factor 9
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FGFR4
|
fibroblast growth factor receptor 4
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FLT3LG
|
fms-related tyrosine kinase 3 ligand
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
FN1
|
fibronectin 1
|
|
FOSL1
|
FOS-like antigen 1
|
|
FOXM1
|
forkhead box M1
|
|
FOXO1
|
forkhead box O1
|
|
FRAT1
|
frequently rearranged in advanced T-cell lymphomas 1
|
|
FRAT2
|
frequently rearranged in advanced T-cell lymphomas 2
|
|
FZD1
|
frizzled class receptor 1
|
|
FZD10
|
frizzled class receptor 10
|
|
FZD2
|
frizzled class receptor 2
|
|
FZD3
|
frizzled class receptor 3
|
|
FZD5
|
frizzled class receptor 5
|
|
FZD6
|
frizzled class receptor 6
|
|
FZD7
|
frizzled class receptor 7
|
|
FZD8
|
frizzled class receptor 8
|
|
FZD9
|
frizzled class receptor 9
|
|
GABPA
|
GA binding protein transcription factor, alpha subunit 60kDa
|
|
GRB2
|
growth factor receptor-bound protein 2
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
HBEGF
|
heparin-binding EGF-like growth factor
|
|
HCFC1
|
host cell factor C1
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HMGB1
|
high mobility group box 1
|
|
HMGN1
|
high mobility group nucleosome binding domain 1
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IL10
|
interleukin 10
|
|
IL1B
|
interleukin 1, beta
|
|
IL34
|
interleukin 34
|
|
IL6
|
interleukin 6
|
|
INS
|
insulin
|
|
INSR
|
insulin receptor
|
|
ITGA1
|
integrin, alpha 1
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGA3
|
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor)
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
|
ITGA6
|
integrin, alpha 6
|
|
ITGAV
|
integrin, alpha V
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITGB4
|
integrin, beta 4
|
|
ITPR3
|
inositol 1,4,5-trisphosphate receptor, type 3
|
|
JAK1
|
Janus kinase 1
|
|
JUN
|
jun proto-oncogene
|
|
KDM6A
|
lysine (K)-specific demethylase 6A
|
|
KDR
|
kinase insert domain receptor
|
|
KIF23
|
kinesin family member 23
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KITLG
|
KIT ligand
|
|
KMT2C
|
lysine (K)-specific methyltransferase 2C
|
|
KREMEN1
|
kringle containing transmembrane protein 1
|
|
LAMA1
|
laminin, alpha 1
|
|
LAMA2
|
laminin, alpha 2
|
|
LAMA3
|
laminin, alpha 3
|
|
LAMA4
|
laminin, alpha 4
|
|
LAMA5
|
laminin, alpha 5
|
|
LAMB1
|
laminin, beta 1
|
|
LAMB2
|
laminin, beta 2 (laminin S)
|
|
LAMB3
|
laminin, beta 3
|
|
LAMC1
|
laminin, gamma 1 (formerly LAMB2)
|
|
LAMC2
|
laminin, gamma 2
|
|
LAMC3
|
laminin, gamma 3
|
|
LATS1
|
large tumor suppressor kinase 1
|
|
LATS2
|
large tumor suppressor kinase 2
|
|
LEF1
|
lymphoid enhancer-binding factor 1
|
|
LGALS9
|
lectin, galactoside-binding, soluble, 9
|
|
LIMD1
|
LIM domains containing 1
|
|
LIN28B
|
lin-28 homolog B (C. elegans)
|
|
LRP5
|
low density lipoprotein receptor-related protein 5
|
|
LRP6
|
low density lipoprotein receptor-related protein 6
|
|
MAD1L1
|
MAD1 mitotic arrest deficient-like 1 (yeast)
|
|
MAD2L1
|
MAD2 mitotic arrest deficient-like 1 (yeast)
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K2
|
mitogen-activated protein kinase kinase 2
|
|
MAP2K3
|
mitogen-activated protein kinase kinase 3
|
|
MAP2K4
|
mitogen-activated protein kinase kinase 4
|
|
MAP2K5
|
mitogen-activated protein kinase kinase 5
|
|
MAP2K6
|
mitogen-activated protein kinase kinase 6
|
|
MAP2K7
|
mitogen-activated protein kinase kinase 7
|
|
MAP3K1
|
mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase
|
|
MAP3K10
|
mitogen-activated protein kinase kinase kinase 10
|
|
MAP3K11
|
mitogen-activated protein kinase kinase kinase 11
|
|
MAP3K2
|
mitogen-activated protein kinase kinase kinase 2
|
|
MAP3K3
|
mitogen-activated protein kinase kinase kinase 3
|
|
MAP3K4
|
mitogen-activated protein kinase kinase kinase 4
|
|
MAP3K5
|
mitogen-activated protein kinase kinase kinase 5
|
|
MAP3K6
|
mitogen-activated protein kinase kinase kinase 6
|
|
MAP3K9
|
mitogen-activated protein kinase kinase kinase 9
|
|
MAP4K1
|
mitogen-activated protein kinase kinase kinase kinase 1
|
|
MAP4K2
|
mitogen-activated protein kinase kinase kinase kinase 2
|
|
MAP4K3
|
mitogen-activated protein kinase kinase kinase kinase 3
|
|
MAP4K4
|
mitogen-activated protein kinase kinase kinase kinase 4
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK10
|
mitogen-activated protein kinase 10
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK7
|
mitogen-activated protein kinase 7
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPK9
|
mitogen-activated protein kinase 9
|
|
MAPKAPK2
|
mitogen-activated protein kinase-activated protein kinase 2
|
|
MAX
|
MYC associated factor X
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MCU
|
mitochondrial calcium uniporter
|
|
MDK
|
midkine (neurite growth-promoting factor 2)
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MDM4
|
MDM4, p53 regulator
|
|
MEF2D
|
myocyte enhancer factor 2D
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MINK1
|
misshapen-like kinase 1
|
|
MKNK1
|
MAP kinase interacting serine/threonine kinase 1
|
|
MKNK2
|
MAP kinase interacting serine/threonine kinase 2
|
|
MLST8
|
MTOR associated protein, LST8 homolog (S. cerevisiae)
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MOB1A
|
MOB kinase activator 1A
|
|
MOB1B
|
MOB kinase activator 1B
|
|
MST1
|
macrophage stimulating 1
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
NDRG1
|
N-myc downstream regulated 1
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
|
NGFR
|
nerve growth factor receptor
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
|
NOTUM
|
notum pectinacetylesterase homolog (Drosophila)
|
|
NTF3
|
neurotrophin 3
|
|
NTF4
|
neurotrophin 4
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
OGT
|
O-linked N-acetylglucosamine (GlcNAc) transferase
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PAK2
|
p21 protein (Cdc42/Rac)-activated kinase 2
|
|
PAK3
|
p21 protein (Cdc42/Rac)-activated kinase 3
|
|
PAK4
|
p21 protein (Cdc42/Rac)-activated kinase 4
|
|
PAK5
|
p21 (RAC1) activated kinase 5
|
|
PAK6
|
p21 protein (Cdc42/Rac)-activated kinase 6
|
|
PDGFA
|
platelet-derived growth factor alpha polypeptide
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PDGFC
|
platelet derived growth factor C
|
|
PDGFD
|
platelet derived growth factor D
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDK1
|
pyruvate dehydrogenase kinase, isozyme 1
|
|
PGF
|
placental growth factor
|
|
PHC1
|
polyhomeotic homolog 1 (Drosophila)
|
|
PIGF
|
phosphatidylinositol glycan anchor biosynthesis, class F
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLCB4
|
phospholipase C, beta 4
|
|
PODXL
|
podocalyxin-like
|
|
PORCN
|
porcupine homolog (Drosophila)
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PRB1
|
proline-rich protein BstNI subfamily 1
|
|
PRB2
|
proline-rich protein BstNI subfamily 2
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKAA2
|
protein kinase, AMP-activated, alpha 2 catalytic subunit
|
|
PRKAB1
|
protein kinase, AMP-activated, beta 1 non-catalytic subunit
|
|
PRKAB2
|
protein kinase, AMP-activated, beta 2 non-catalytic subunit
|
|
PRKAG1
|
protein kinase, AMP-activated, gamma 1 non-catalytic subunit
|
|
PRKAG2
|
protein kinase, AMP-activated, gamma 2 non-catalytic subunit
|
|
PRKAG3
|
protein kinase, AMP-activated, gamma 3 non-catalytic subunit
|
|
PRSS23
|
protease, serine, 23
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTK2
|
protein tyrosine kinase 2
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RASSF2
|
Ras association (RalGDS/AF-6) domain family member 2
|
|
RASSF3
|
Ras association (RalGDS/AF-6) domain family member 3
|
|
RASSF4
|
Ras association (RalGDS/AF-6) domain family member 4
|
|
RASSF5
|
Ras association (RalGDS/AF-6) domain family member 5
|
|
RASSF6
|
Ras association (RalGDS/AF-6) domain family member 6
|
|
RASSF7
|
Ras association (RalGDS/AF-6) domain family (N-terminal) member 7
|
|
RB1CC1
|
RB1-inducible coiled-coil 1
|
|
RBBP4
|
retinoblastoma binding protein 4
|
|
RHEB
|
Ras homolog enriched in brain
|
|
RING1
|
ring finger protein 1
|
|
RNF2
|
ring finger protein 2
|
|
ROR1
|
receptor tyrosine kinase-like orphan receptor 1
|
|
ROR2
|
receptor tyrosine kinase-like orphan receptor 2
|
|
RPS6
|
ribosomal protein S6
|
|
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1
|
|
RPS6KA3
|
ribosomal protein S6 kinase, 90kDa, polypeptide 3
|
|
RPS6KA5
|
ribosomal protein S6 kinase, 90kDa, polypeptide 5
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RPS6KB2
|
ribosomal protein S6 kinase, 70kDa, polypeptide 2
|
|
RPTOR
|
regulatory associated protein of MTOR, complex 1
|
|
RYK
|
receptor-like tyrosine kinase
|
|
SAV1
|
salvador family WW domain containing protein 1
|
|
SELE
|
selectin E
|
|
SENP2
|
SUMO1/sentrin/SMT3 specific peptidase 2
|
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
|
|
SETD2
|
SET domain containing 2
|
|
SETD5
|
SET domain containing 5
|
|
SETDB1
|
SET domain, bifurcated 1
|
|
SFRP1
|
secreted frizzled-related protein 1
|
|
SFRP2
|
secreted frizzled-related protein 2
|
|
SFRP4
|
secreted frizzled-related protein 4
|
|
SFRP5
|
secreted frizzled-related protein 5
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC3A2
|
solute carrier family 3 (amino acid transporter heavy chain), member 2
|
|
SLC7A5
|
solute carrier family 7 (amino acid transporter light chain, L system), member 5
|
|
SOS1
|
son of sevenless homolog 1 (Drosophila)
|
|
SOST
|
sclerostin
|
|
SOX17
|
SRY (sex determining region Y)-box 17
|
|
SP1
|
Sp1 transcription factor
|
|
SPARC
|
secreted protein, acidic, cysteine-rich (osteonectin)
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STK3
|
serine/threonine kinase 3
|
|
STK38L
|
serine/threonine kinase 38 like
|
|
SUZ12
|
SUZ12 polycomb repressive complex 2 subunit
|
|
TCF7
|
transcription factor 7 (T-cell specific, HMG-box)
|
|
TCF7L1
|
transcription factor 7-like 1 (T-cell specific, HMG-box)
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TEAD1
|
TEA domain family member 1 (SV40 transcriptional enhancer factor)
|
|
TEAD2
|
TEA domain family member 2
|
|
TEAD3
|
TEA domain family member 3
|
|
TEAD4
|
TEA domain family member 4
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
TELO2
|
telomere maintenance 2
|
|
TERT
|
telomerase reverse transcriptase
|
|
TGFA
|
transforming growth factor, alpha
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TNIK
|
TRAF2 and NCK interacting kinase
|
|
TNNT1
|
troponin T type 1 (skeletal, slow)
|
|
TP53
|
tumor protein p53
|
|
TRAF2
|
TNF receptor-associated factor 2
|
|
TSC1
|
tuberous sclerosis 1
|
|
TSC2
|
tuberous sclerosis 2
|
|
TTI1
|
TELO2 interacting protein 1
|
|
UHRF1
|
ubiquitin-like with PHD and ring finger domains 1
|
|
ULK1
|
unc-51 like autophagy activating kinase 1
|
|
ULK2
|
unc-51 like autophagy activating kinase 2
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFB
|
vascular endothelial growth factor B
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
VEGFD
|
vascular endothelial growth factor D
|
|
VGLL4
|
vestigial-like family member 4
|
|
WDR5
|
WD repeat domain 5
|
|
WIF1
|
WNT inhibitory factor 1
|
|
WNT1
|
wingless-type MMTV integration site family, member 1
|
|
WNT10A
|
wingless-type MMTV integration site family, member 10A
|
|
WNT10B
|
wingless-type MMTV integration site family, member 10B
|
|
WNT11
|
wingless-type MMTV integration site family, member 11
|
|
WNT16
|
wingless-type MMTV integration site family, member 16
|
|
WNT2
|
wingless-type MMTV integration site family member 2
|
|
WNT2B
|
wingless-type MMTV integration site family, member 2B
|
|
WNT3
|
wingless-type MMTV integration site family, member 3
|
|
WNT3A
|
wingless-type MMTV integration site family, member 3A
|
|
WNT4
|
wingless-type MMTV integration site family, member 4
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
|
WNT5B
|
wingless-type MMTV integration site family, member 5B
|
|
WNT6
|
wingless-type MMTV integration site family, member 6
|
|
WNT7A
|
wingless-type MMTV integration site family, member 7A
|
|
WNT7B
|
wingless-type MMTV integration site family, member 7B
|
|
WWC1
|
WW and C2 domain containing 1
|
|
WWTR1
|
WW domain containing transcription regulator 1
|
|
YAP1
|
Yes-associated protein 1
|
|
YWHAB
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta
|
|
YY1
|
YY1 transcription factor
|
